For the year ending 2025-12-31, PTCT has $2,898,767K in assets. $3,104,080K in debts. $984,648K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 984,648 | |||
| Marketable securities | 960,723 | |||
| Trade and royalty receivables, net | 181,621 | |||
| Inventory, net | 79,647 | |||
| Prepaid expenses and other current assets | 67,309 | |||
| Total current assets | 2,273,948 | |||
| Fixed assets, net | 55,371 | |||
| Intangible assets, net | 388,753 | |||
| Goodwill | 82,341 | |||
| Operating lease rou assets | 80,053 | |||
| Deposits and other assets | 18,301 | |||
| Total assets | 2,898,767 | |||
| Accounts payable and accrued expenses | 381,272 | |||
| Current portion of long-term debt | 286,631 | |||
| Deferred revenue | 2,040 | |||
| Operating lease liabilities- current | 12,484 | |||
| Finance lease liabilities- current | 3,000 | |||
| Liability for sale of future royalties- current | 283,000 | |||
| Total current liabilities | 968,427 | |||
| Operating lease liabilities- noncurrent | 93,583 | |||
| Finance lease liabilities- noncurrent | 3,000 | |||
| Liability for sale of future royalties- noncurrent | 2,025,366 | |||
| Other long-term liabilities | 13,704 | |||
| Total liabilities | 3,104,080 | |||
| Common stock, 0.001 par value. authorized 250,000,000 shares issued and outstanding 81,474,366 shares at december 31, 2025. authorized 250,000,000 shares issued and outstanding 77,704,188 shares at december 31, 2024 | 80 | |||
| Additional paid-in capital | 2,748,335 | |||
| Accumulated other comprehensive income (loss) | 10,501 | |||
| Accumulated deficit | -2,964,229 | |||
| Total stockholders' deficit | -205,313 | |||
| Total liabilities and stockholders' deficit | 2,898,767 | |||
PTC THERAPEUTICS, INC. (PTCT)
PTC THERAPEUTICS, INC. (PTCT)